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Abstract
Background Having a familial member affected by cutaneous melanoma is a risk factor for this neoplasm. Only a
few epidemiological case–control studies have been carried out to investigate whether familial and sporadic
melanomas show different clinical and histopathological features.
Objective The aim of this study was to evaluate eventual different features and risk factors in subjects affected by
familial and sporadic cutaneous melanoma.
Methods A case–control multicentre study interesting 1407 familial (n = 92) and sporadic (n = 1315) melanomas in
the Italian population. The analysis was made using t-test for continuous variables and chi-squared test for
categorized ones. The variables which have shown statistically significant differences in the two groups in the
univariate analysis were included in a multivariate model.
Results The results showed some main significantly clinical differences between the two groups investigated:
earlier age at diagnosis, a greater proportion of sunburns and a higher number of naevi were observed for the
familial cases compared with sporadic ones. Nevertheless, we did not find a diagnostic anticipation in familial
melanomas, in fact the invasion level and the thickness of melanomas was similar in the two groups.
Conclusion Some relevant clinical differences are observed between the two groups examined. The familial
melanoma members, although carriers of constitutional risk factors, are not careful enough to primary and
secondary prevention.
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Introduction
A familial member affected by cutaneous melanoma is a risk factor
for this neoplasm.1 Approximately 8–12% of melanoma cases
develop in predisposed kindred,1 with at least two cases in the
same family.
It is well-known that constitutional and environmental mela-
noma risk factors closely interact, in a complex and not yet fully
clarified manner. Among the constitutional risk factors, the high
number of melanocytic naevi and ⁄or the presence of atypical naevi
play an important role, as well as sun exposure, currently consid-
ered a crucial environmental risk factor, especially if intense and
intermittent. The demonstrated risk factors do act independently,
yet they can also be related in subsequent events that can promote
the melanoma growth.
Only a few epidemiological case–control studies have been car-
ried out to investigate the clinical features of familial and sporadic
melanomas. These investigations mainly evaluated the diagnostic
anticipation (by means of the age of diagnosis and the thickness of
melanoma). This particular point is still controversial, although
generally an earlier growth of familial melanoma is found. Two1See Appendix.
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recent case–control studies carried out on Mediterranean popula-
tions confirmed these findings.2,3
The aim of our study was to investigate individual characteris-
tics and clinical and histopathological differences between familial
and sporadic melanoma in an Italian population by means of a
multicentre study.
Patients and methods
In the study, we included 1407 newly diagnosed melanoma cases,
both in situ (n 252, 17.9%) and invasive (n 1155, 82.1%), consecu-
tively observed in 27 Italian pigmented lesion clinics from 2004 to
2005. The number of melanoma cases provided by centres ranged
from 13 to 155. All participating centres were members of the
GIPMe (Italian Multidisciplinary Group on Melanoma), a
national scientific association which promotes research in the field
of study and care of cutaneous melanoma. The centres are rather
uniformly distributed in the National area.
According to the study protocol, a detailed questionnaire was
filled out for each patient at the time of histologically confirmed
diagnosis of cutaneous melanoma. The following variables were
collected by a dermatologist expert in pigmented lesions’ diagnosis:
1 Demographic and phenotypic features, which included age at
diagnosis, gender, years of school education, height (meter),
weight (kg), eye colour (collected as black, brown, green, blue
and grey; then grouped in dark: black and brown, and fair:
blue, green and grey), skin colour (fair, intermediate, dark),
phototype according to Fitzpatrick (I–IV), a count of total
body naevi, melanocytic naevi >6 mm and atypical naevi
(>6 mm with irregular borders and dishomogeneous colour).
2 Melanoma features: date of excision, anatomical site
(head ⁄neck, upper limbs, trunk, lower limbs and hand ⁄
foot), histological subtype [superficial spreading melanoma
(SSM), nodular melanoma (NM), acral lentiginous mela-
noma (ALM), lentigo malignant (LM) and lentigo malig-
nant melanoma (LMM), not otherwise specified melanoma
(NOS)], Breslow’s thickness, Clark’s level, ulceration (pres-
ent ⁄ absent) and melanoma on naevus. To evaluate the
effect of sun exposure, we evaluated head and neck – con-
sidered as chronically sun exposed – vs., shoulder and back
– considered as intermittently exposed.
3 Lifetime history of sunburns: number of life-time sunburns
(none, 1–5, >5), age at first and last sunburns were
included. The presence of solar keratosis (0, 1+) was also
collected.
4 Family history of melanoma. In this study we defined the
familial status according to definition of at least two mela-
noma cases (one proband plus one other affected individ-
ual) among relatives up to a second degree of relationship.
These criteria can be sufficient in Italy, a country with rela-
tively low incidence, although the Genetics Melanoma Con-
sortium defined for genetic counselling the presence of at
least two affected relatives of first degree or three or more
melanoma cases in the same side of the family.4 Although
some authors extend the familial status to the presence of
an affected relative up to a third degree of relationship,5 we
preferred more conservative criteria to minimize as much
as possible the risk of misclassification in recall, that
becomes more frequent if the medical history of relatives is
more distant than second degree.6 Although melanoma
family history was available as first (n: 65 cases, 70.6%) or
second (n: 27 cases, 29.4%) degree, we pooled together the
two categories.
There are some missing values for some variables and we could
not recover the data from the participant centres. The percentage
of missing data ranged from 0.8% to 5.8% for the demographic
and melanoma features (Table 1), and from 0.7% to 2.4% for
phenotypic features (Table 2). The missing values are shown in
Tables 1 and 2.
We computed the body surface area (BSA) according to the
DuBois & DuBois formula [BSA (m2) = 0.20247 · height (m)0.725
· weight (kg)0.425].7 The total quantity of naevi is calculated either
as density or as average. The density of naevi (total, >6 mm and
atypical) was referred to the BSA (number of naevi ⁄BSA).
Differences in the frequency of each variable between familial
and non-familial cases were analysed using t-test for continuous
variables and chi-squared test for categorized ones. Fisher’s exact
test was used, when there were five or less expected values. Medi-
ans were compared with the Mann–Whitney test. The association
between the demographic, phenotypic and histopathological fea-
tures and the familial status of melanoma was then assessed by
conducting univariate and multivariate logistic regression analyses.
The measure of the association used was the odds ratio (OR) and
the corresponding 95% confidence interval was computed.
The variables which have shown statistically significant differ-
ences in the two groups in the univariate analysis were tested for
being included in a multivariate model by means of stepwise pro-
cess. The effect of each variable in improving the model was evalu-
ated by means of the Likelihood-ratio test, which compared the
model with and without the variables. The probability threshold
used was 0.05. The logistic regression analyses were adjusted by
centre.
Results
In this multicentre study, we collected 1407 melanomas, 1315
(93.5%) sporadic and 92 (6.5%) familial (Table 1). The age at
diagnosis was significantly different with a younger median age for
familial melanoma (median age at diagnosis 47 years, range 23–
83) than for sporadic ones (median age 55 years, range 10–95)
(P < 0.001). No differences were found between men and women.
The familial melanoma group showed a higher level of education
(>8 years of education: 65.2% vs. 51.6%, P = 0.012).
The clinical and histopathological features and the main
prognostic factors of melanomas were similar for familial and spo-
radic cases (Table 1). The anatomical site distribution of tumour
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(face ⁄neck, trunk, upper limbs and lower limbs) was not different
between the two groups, even when analysed separately for males
and females. The higher incidence of tumours was on the lower
limbs in females and on the trunk in males, as well-known from
the literature (data not shown). Concerning the anatomical site in
relationship to sun-exposure (head ⁄neck vs. shoulder ⁄back as pro-
totype of chronic and intermittent sun-exposure respectively),
there was an almost significant difference between the two groups
(P = 0.077).
Regarding the histotype, the percentage of nodular melanoma
and superficial spreading melanoma showed an almost significant
difference (P = 0.074) between familial and sporadic cases, with a
greater percentage of superficial spreading melanoma observed for
familial cases. Interestingly, in the familial group, there were no
ALM and LM ⁄LMM cases.
The comparison of the main prognostic pathological factors
(Clark level, Breslow thickness and ulceration) did not show any
difference between the two groups. Interestingly, a significantly
greater proportion of melanoma with remnant naevus was found
among familial cases than among sporadic ones (P = 0.037).
No differences were found between familial and sporadic mela-
noma concerning phenotype (skin colour and eye colour) and
phototype (Table 2).
A different history of sunburns was found between the two
groups: 45.6% of familial melanoma cases vs. 27.1% of sporadic
cases (P = 0.001) had in their lifetime a number of sunburns > 5.
Conversely, there was no difference concerning age of primary
sunburn: median age 12 years in sporadic melanoma cases vs.
10 years in familial ones (data not shown). Moreover, the presence
of actinic keratosis did not differ between sporadic and familial
melanoma (Table 2).
Table 1 Distribution of demographic and histopathological fea-








n (%) n (%)
Age
Median (range) 47 (23–83) 55 (10–95) <0.001
Gender
Men 50 (54.4) 642 (48.8) 0.31
Women 42 (45.7) 673 (51.2)
Education (m.v. = 11)
£8 years 32 (34.8) 631 (48.4) 0.012
>8 years 60 (65.2) 673 (51.6)
Melanoma site (m.v. = 82)
Head & neck 6 (7.1) 149 (12.1) 0.21
Trunk 46 (54.8) 544 (43.8)
Upper limb 10 (11.9) 193 (15.6)
Lower limb 22 (26.2) 355 (28.6)
Sun exposure
Chronic
Head & neck 4 (11.8) 119 (25.2)
Intermittent
Shoulder, back 30 (88.2) 353 (74.8) 0.077
Histological subsite (m.v. = 12)
SSM 79 (85.9) 1037 (79.7) 0.074
NM 9 (9.8) 155 (11.9)
ALM 0 17 (1.3)
LM-LMM 0 65 (5.0)
NOS 4 (4.4) 27 (2.1)
Breslow thickness (for invasive only)
<1 mm 46 (62.2) 639 (59.1) 0.61
‡1 mm 28 (37.8) 442 (40.9)
Clark’s level
I 18 (19.6) 234 (17.8) 0.64
II 30 (32.6) 408 (31.0)
III 21 (22.8) 335 (25.5)
IV 23 (25.0) 306 (23.3)
V 0 32 (2.4)
Ulceration (m.v. = 27)
No 79 (87.8) 1131 (87.7) 0.977
Yes 11 (12.2) 159 (12.3)
MM on naevus (m.v. = 70)
No 61 (67.8) 965 (77.4) 0.037
Yes 29 (32.2) 282 (22.6)
SSM, superficial spreading melanoma; NM, nodular melanoma; ALM,
acral lentiginous melanoma; LM, malignant lentigo; LMM, malignant mel-
anoma on lentigo; NOS, not otherwise specified; m.v., missing values.









n (%) n (%)
Phototype (m.v. = 23)
I–II 51 (56.7) 689 (53.3) 0.539
III–IV 39 (43.3) 603 (46.7)
Eye colour (m.v. = 10)
Dark 45 (50.0) 726 (55.6) 0.306
Fair 45 (50.0) 581 (44.4)
Skin colour (m.v. = 17)
Dark 34 (37.4) 524 (40.3) 0.807
Intermediate 51 (56.0) 682 (52.5)
Fair 6 (6.6) 93 (7.2)
Number of lifetime sunburns (m.v. = 32)
None 16 (17.8) 372 (29.0) <0.001
1–5 33 (36.7) 565 (44.0)
>5 41 (45.6) 348 (27.1)
Actinic keratosis (m.v. = 34)
0 79 (87.8) 1040 (81.1) 0.113
1 or + 11 (12.2) 243 (18.9)
m.v., missing values.
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The naevi count showed that the patients with familial mela-
noma had both a greater density (27.2 ⁄m2 familiar and 20.0 spo-
radic, P = 0.015) and a greater mean number (50.2 vs. 35.6,
P = 0.0047) of total melanocytic naevi than patients with sporadic
melanomas. Such difference was confirmed also for single anatom-
ical sites (Table 3). A greater number and a greater density in
patients with familial melanoma than in sporadic ones was also
documented for naevi >6 mm and for atypical ones.
In the univariate analysis (Table 4), familial melanomas were
significantly more frequent than sporadic ones to have more than
8 years of school education (OR = 1.77; 95% CI, 1.13–2.74), MM
on naevus (OR = 1.63; 95% CI, 1.03–2.58), a growing number of
lifetime sunburns (OR = 1.36 for 1–5 sunburns; 95% CI,
0.74–2.50 and, OR = 2.74 for more than 5 sunburns; 95% CI,
1.51–4.79) a growing number of naevi (OR = 1.005; 95% CI,
1.001–1.008), a growing number of naevi > 6 mm (OR = 1.04;
95% CI, 1.02–1.07) and a growing number of typical naevi
(OR = 1.05; 95% CI, 1.02–1.09). On the contrary, the risk of hav-
ing a familial melanoma decreased as age increased (OR = 0.98;
95% CI, 0.97 – 0.99). The multivariate logistic regression analysis
showed that the best model was the one including age, number of
sunburns, number of naevi >6 mm and number of atypical naevi.
The effect of the centre was also evaluated but did not have any
effect in improving the model neither changed the coefficients.
The risk of having a familial melanoma instead of a sporadic one
was slightly but significantly reduced as age at diagnosis increased.
Moreover, the increase in the number of sunburns is in propor-
tion with the increase in the risk of familial melanoma. In the
multivariate model, the increase in the risk of familial melanoma
was in proportion with the increase in the number of greater naevi
and of atypical naevi (Table 4).
Discussion
The family history of melanoma is a risk factor for this tumour,
even independent from demonstrated genetic alteration of gene(s)
known as involved in its development.1
We investigated by means of an epidemiological case–control
study whether familial melanomas show different clinical and
pathological features from sporadic ones.
The study showed some points of strength:
1 A series with a considerable number of cases (1407 histo-
logically confirmed melanomas).
2 A clinical record concerning clinical, pathological, pheno-
typical data, including the number of melanocytic naevi
specified for clinical type and anatomical site and sunburns
history.
3 A multicentre study (GIPMe) with 27 participating centres
uniformly distributed in Italian peninsula.
There are some limitations in the study:
1 The familial status was based on patients’ self-reported fam-
ily history. In fact the misunderstanding ‘melanoma ⁄ non-
melanoma skin cancer’ is possible, as well as the lacking
knowledge of the datum.8 To minimize the risk of recall
misclassification, we applied the stringent criteria of famil-
iarity no more distant than second degree.6
2 Unfortunately, the multiple primary melanoma (MPM)
datum is missing in our questionnaire because the main
idea of this investigation was to evaluate the melanoma
density in the different skin anatomical areas (analysis of
the data is ongoing). The investigation about the features of
familial vs. sporadic melanoma is born later and the collec-
tion of some data it was’nt foreseen, therefore we could not
consider the MPM variable. According to the literature, the









Mean number of naevi 50.2 35.6 0.0047
Naevi density 27.2 20.0 0.015
Mean number of naevi for sub sites
Head and neck 2.5 1.9 0.08
Trunk 16.5 12.8 0.03
Upper limbs 14.3 10.1 0.01
Lower limbs 15.4 10.0 0.009
Mean number of naevi >6 mm 4.69 2.69 <0.001
Density of naevi >6 mm 2.65 1.48 <0.001
Mean number of atypical naevi 2.73 1.41 0.0027
Density of atypical naevi 1.43 0.79 0.0097
No missing values.
Table 4 Crude and adjusted odds ratio (OR) and 95% confi-
dence intervals (95% CI) for familial melanoma in comparison
with sporadic one
Features Crude OR (95% CI) Adjusted* OR
(95% CI)
Age 0.98 (0.97–0.99) 0.98 (0.97–1.00)
Education
<8 years 1




Number of lifetime sunburns
None 1 1
1–5 1.36 (0.74–2.50) 1.15 (0.62–2.14)
>5 2.74 (1.51–4.97) 2.24 (1.22–4.12)
Number of naevi 1.005 (1.001–1.008)
Number of naevi >6 mm 1.04 (1.02–1.07) 1.03 (1.00–1.07)
Number of atypical naevi 1.05 (1.02–1.09) 1.04 (1.01–1.07)
*Adjusted for age, lifetime sunburns, number of naevi >6 mm, number
of atypical naevi.
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presence of multiple melanoma in high risk families is more
frequent than in sporadic melanoma,2,9 nevertheless this is
a controversial question.10
As a general warning, we have to point out that as a number of
comparisons were performed, some of them may be statistically
significant by chance.11
Moreover, the proportion of familial melanoma in this study
(6.5%) agrees with what already published;2 however, their abso-
lute number is relatively small (n.92) and therefore results may be
affected by low statistical power.
This study highlighted some interesting aspects. The trend
reported in the literature for an earlier age at diagnosis in familial
melanomas than in sporadic ones2,3,10,12 is confirmed. On the con-
trary, there are no differences between the two groups under study
concerning the main histopathological prognostic factors: Clark’s
level and Breslow’s thickness are almost overlapping. Other
authors found similar results.10 Therefore, we can hypothesize that
in the family cases, there is not a diagnostic anticipation, that is to
say an earlier diagnosis caused by a better skin self-examination or
by more frequent medical skin examination attributable to
increased awareness concerning risk, but it could be a genetic and
biological pressure causing earlier onset of tumour. In this regard,
an interesting study showed that in high risk melanoma kindred, a
progressively earlier age at diagnosis in successive generations
exists, but there is not any difference in melanoma thickness.13
The main genetic factor implicated in this anticipation is consid-
ered the CDKN2A mutation. Nevertheless, this aspect in our study
remains at hypothesis level because it is a clinical ⁄ epidemiological
investigation and our familial melanoma cases were not investi-
gated regarding the mutation status.
The familial group demonstrated a greater proportion of sun-
burns. This is a remarkable result, which leads to some specula-
tions. We could think that there are some differences concerning
phenotype and ⁄or phototype responsible for a greater UV cutane-
ous sensitivity. On the contrary, the univariate analysis showed
that such clinical features are overlapping between familial and
sporadic melanomas. We can hypothesize that familial cases could
have an intrinsic cutaneous sensitivity not totally evident by
‘rough’ clinical ⁄ anamnestic classifications about skin colour and
phototype, but could derive from some genetic characteristics (i.e.
MC1R, DNA Repair capacity or other genes not yet known).14–16
Anyhow, independent of cutaneous sensitivity, the high number
of sunburns demonstrates that familial cases are not more careful
than sporadic melanomas towards the primary prevention. This
aspect is also shown in other high risk melanoma groups, as
patients with Atypical Mole Syndrome and patients with previous
melanoma. Both of them continue to have an excess of sun expo-
sure.17–19
The number of naevi was, on average, significantly greater in
familial cases, and this is particularly evident for the ‘great naevi’
and the clinically atypical naevi, especially those located on the
trunk and the lower limb (data not shown). In the literature, the
evaluation of nevi in familial vs. sporadic melanomas was analy-
sed, although partially and with conflicting results, in a small
number of studies.2,9,20
We could wonder whether the higher number of melanocytic
naevi, either great or atypical ones, depends on more numerous
sunburns or is an independent factor in relationship with a genetic
pressure responsible for a higher melanocytic cell proliferation,
possibly, for an earlier melanoma growth. A large number of naevi
and of atypical naevi in high risk kindreds with CDKN2A muta-
tion was considered to be caused by a responsible gene.21 Never-
theless, genetic studies on members of melanoma families
highlighted that atypical naevi did not show co-segregation with
CDKN2A mutation found in some kindred.22 It is likely that other
types of genes, not yet identified, are involved in both naevi devel-
opment and melanoma onset. Recently, it was been found that
polymorphisms on chromosome 9 and 22 were associated with
increased numbers of naevi and larger naevi.23
Another point of interest is the more frequent association of
melanoma on naevus with familial cases. A study shows that mela-
noma arises from a pre-existent naevus in about 20–30% cases.24
The percentage in our study was 22.6% in sporadic melanomas
and 32.2% in familial cases. Nevertheless, this difference disap-
peared in the multivariated analysis and we can hypothesize that
this finding is the consequence of a higher number of melanocytic
naevi and ⁄or of sunburns, as previously hypothesized.25
In conclusion, this clinical study highlights some differences
between familial and sporadic melanomas. We can not exclude
that some results are chance, because of small sample size (92
familial melanoma cases) and can not be conclusive. Nevertheless,
we think that these results lead some remarkable scientific, biologi-
cal and health educational suggestions. Concerning this latter
aspect, our investigation suggests that members of melanoma kin-
dred, although carriers of constitutional risk factors (melanocytic
nevi and familial melanoma), are not careful enough with regard
to primary (numerous sunburns) or secondary prevention (no
diagnostic anticipation). It could be very important to develop
prevention strategies for such subgroups of subjects. For example,
it could be useful to collect systematically information on the fam-
ily history of melanoma during dermatological consultations, to
alert patients about a possible higher risk.
The physicians should invite the individuals diagnosed with
cutaneous melanoma to involve their healthy relatives in preven-
tion practices, especially submitting to clinical examination.
In healthy relatives of a melanoma patient, it could be very
important to emphasize which are the risk factors and the wrong
behaviours; to improve the knowledge and practice of preventive
measures of sun protection, to suggest regular skin self-examina-
tion and at least annual medical examination.
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Appendix
The other GIPMe participants centres:
M.G. Bernengo, MD (Department of Biomedical Sciences and
Human Oncology, 1st Dermatologic Division, University of
Turin, Turin), R. Betti, MD (Dermatologic Clinic, University
of Milan, S. Paolo Hospital, Milan), G.L. Imberti, MD (Der-
matology Clinics, Ospedali Riuniti, Bergamo), W. Wallnofer,
MD and C. Carriere, MD (Dermatology Unit, Hospital of
Bolzano, Bolzano), G. Pellacani, MD and S. Seidenari, MD
(Department of Dermatology, University of Modena and Reg-
gio Emilia, Modena), P. Mulas, MD (Dermatology Units, Bus-
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